A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/195 (2006.01) A23L 1/305 (2006.01) A61K 31/198 (2006.01)
Patent
CA 2239582
Glycine is indicated to prevent or treat acute or chronic graft rejection, optionally in combination with an immunosuppressant or an immunomodulating agent.
Cook Nigel Scott
Schneider Heinz
Fetherstonhaugh & Co.
Novartis Ag
Novartis Nutrition Ag
LandOfFree
A new therapeutic use for glycine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A new therapeutic use for glycine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A new therapeutic use for glycine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1410071